Related Experiment Video
Updated: May 24, 2026

Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
Coagulopathy and hemostatic monitoring in cardiac surgery: an update
Pär I Johansson1, Sacha Sølbeck, Gustav Genet
1Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, University of Copenhagen, Denmark. per.johansson@rh.regionh.dk
Insights
Viscoelastic hemostatic assays (VHA) outperform routine coagulation tests in predicting bleeding and reducing transfusions after cardiac surgery. Real-time monitoring with VHA ensures timely hemostatic therapy for patients undergoing cardiopulmonary bypass.
Area of Science:
- Cardiovascular Surgery
- Hematology
- Anesthesiology
Background:
- Cardiac surgery using cardiopulmonary bypass (CPB) frequently causes hemostatic system derangements.
- These derangements increase risks of microvascular bleeding, excessive transfusion, and surgical re-exploration, potentially leading to adverse outcomes and increased mortality.
Purpose of the Study:
- To review coagulopathies in cardiac surgery and their monitoring.
- To compare the efficacy of viscoelastic hemostatic assays (VHA) versus routine coagulation tests (RCoT) in managing bleeding and transfusion needs.
Main Methods:
- A review of coagulopathies in cardiac surgery.
- Analysis of 16 studies (over 3250 patients, including 3 RCTs) comparing VHA to RCoT.
- Evaluation of VHA's ability to predict bleeding, re-do surgery, and influence transfusion requirements.
Main Results:
- All 16 studies showed VHA superiority over RCoT in predicting bleeding and the need for re-do surgery.
- VHA-guided therapy significantly reduced total blood product transfusions compared to RCoT-based therapy or clinician discretion.
Conclusions:
- Effective management of cardiac surgery coagulopathies requires timely hemostatic therapy.
- Real-time monitoring with VHA, including TEG/ROTEM and whole blood platelet aggregometry, is crucial for optimal patient care.
Objectives:
Cardiac surgery with cardiopulmonary bypass (CPB) causes severe derangements in the hemostatic system, which in turn puts the patient at risks of microvascular bleeding. Excessive transfusion and surgical re-exploration after cardiac surgery are potentially associated with a number of adverse outcomes including increased mortality.
Design:
This review describes coagulopathies occurring in cardiac surgery and the monitoring of these. Viscoelastic hemostatic assays (VHA) have routinely been used in cardiac surgery for more than 25 years and at least 16 studies (involving more than 3250 patients, including three randomized controlled trials) have compared VHA to routine coagulation tests (RCoT) with regards to their ability to predict bleeding and re-do surgery and also with regards to transfusion requirements secondary to hemostatic therapy based on VHA vs. RCoT.
Results:
All 16 studies demonstrated superiority with VHA as compared to RCoT both in predicting bleeding and need for re-do surgery and in reducing the total amount of blood transfusions by employing goal-directed administration of blood products based on VHA as compared RCoT based therapy or at the clinicians discretion.
Conclusions:
The different types of coagulopathies observed in patients undergoing cardiac surgery requires adequate and timely hemostatic therapy and real-time monitoring with WHA such as TEG/ROTEM and whole blood platelet aggregometry.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Aneurysm IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Cardiac Catheterization IV: Nursing Management